Document is current
Any future updates will be listed below
-
Authors
Chonira, Vikas https://orcid.org/0000-0002-9688-313X
Kwon, Young D. https://orcid.org/0000-0002-1188-7458
Gorman, Jason https://orcid.org/0000-0002-3775-6560
Case, James Brett https://orcid.org/0000-0001-7331-5511
Ku, Zhiqiang
Simeon, Rudo
Casner, Ryan G.
Harris, Darcy R.
Olia, Adam S.
Stephens, Tyler
Shapiro, Lawrence
Bender, Michael F.
Boyd, Hannah https://orcid.org/0000-0002-0762-0419
Teng, I-Ting
Tsybovsky, Yaroslav https://orcid.org/0000-0002-2159-5248
Krammer, Florian
Zhang, Ningyan
Diamond, Michael S. https://orcid.org/0000-0002-8791-3165
Kwong, Peter D. https://orcid.org/0000-0003-3560-232X
An, Zhiqiang
Chen, Zhilei https://orcid.org/0000-0002-0244-3556
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DP2AI136600, R01 AI157155, 75N93019C00051, 75N93021C00014, 75N93021C00017, R01 AI157155, DP2AI136600)
- License Information
-
More Information
Article History
Received: 19 February 2022
Accepted: 30 September 2022
First Online: 21 November 2022
Competing interests
: M.S.D. is a consultant for Inbios, Vir Biotechnology, Senda Biosciences, Moderna and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Moderna, and Emergent BioSolutions. F.K. has consulted for Merck, Seqirus, Curevac and Pfizer and is currently consulting for Pfizer, Third Rock Ventures, Merck and Avimex. The F.K. laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2. V.C., R.S. and Z.C. have filed a patent on the sequences for the DARPins. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.
